Corex group of companies provides a full range of services in the sphere of clinical trial logistics. Established in 2011, our brand is renowned for its professional expertise in the post-Soviet countries and in Eastern Europe. COREX has also become an undisputed regional leader in reference and concomitant medications supply.
The past 18 months have been marked by explosive growth and today the company continues its momentous course of accelerated business expansion.
The beginning of 2019 has been marked by the launch of the new logistics hub in Ukraine that has greatly increased the company’s influence in the post-Soviet markets.
The company prides itself on having a fully transparent logistics chain and its innovative IT projects are being continuously implemented with the goal of improving customers’ satisfaction while significantly simplifying real-time communications and document management.
COREX has successfully renewed its ISO 9001:2015 and GDP certificates, confirming yet again its adherence to the standards of excellence and the highest level of its quality management system.
2018 was highlighted by the launch of the “Breakfast with a Logistician” event. “Breakfast” is a novel professional platform where industry experts can discuss noteworthy issues in the field of clinical research logistics as it pertains to Russia, former CIS countries and the countries of Eastern Europe.
The aforementioned developments are signifying both qualitative and quantitative leaps made by the company, making it a perfect time to update its corporate style.
Without any further ado COREX presents to you its new company logo!
And while the image of the company has changed, its CORE values remain the same, bespoken by its original slogan - «excellence in clinical trial logistics»!
The pharmaceutical industry has faced numerous challenges since the beginning of 2021 including the rush to supply COVID-19 vaccines. The start of the year also saw the departure of the UK from the EU and theEuropean Medicines Agency (EMA). The Medicines and Healthcare Products Regulatory Agency (MHRA) is now fully in charge of all regulatory matters, oversight of clinical research and approval of medicines.
We’re here to help. Email us at email@example.com or use our feedback form to send us your question.